Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug, as pharmaceutical…
Tag: specialized drugs
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B
Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The…
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2 Billion
Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The…
GSK PLC Raises Guidance After RSV Vaccine Lifts Earnings
Updated Nov. 1, 2023 4:08 am ET GSK PLC raised its guidance after third-quarter net profit…
‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon
Merck and Pfizer are the latest big pharma companies to invest in this booming area.
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at…
WSJ News Exclusive | CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them
Updated Oct. 20, 2023 11:00 am ET CVS Health is pulling some of the most common…